SEC Filing Summary
Business Context and Reporting Period
This Form 8-K was filed by GX Acquisition Corp., not Celularity Inc., on December 2, 2020. The filing reports corporate governance matters related to the company’s 2020 annual meeting of stockholders.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus Prior Period
No operating or financial changes versus a prior comparable period are disclosed.
Guidance, Outlook, Risks, and Unusual Items
- The 2020 annual meeting of stockholders was scheduled for Tuesday, December 29, 2020.
- The meeting time and location were to be specified in the company’s definitive proxy statement.
- Stockholder proposals or director nominations were required to be delivered to the company’s principal executive offices by December 12, 2020.
- Proposals and nominations were also required to comply with applicable Delaware law, SEC rules, and the company’s bylaws.
Investor Verification Items
- Verify that the filing pertains to GX Acquisition Corp. rather than Celularity Inc.
- Review the subsequent definitive proxy statement for the annual meeting time, location, and related voting matters.
- Confirm whether any stockholder proposals or director nominations were submitted by the December 12, 2020 deadline.